9 results about "Ophthalmic use" patented technology

Provided herein are biopolymers comprising repeating polysaccharide units, preparations of biopolymers, and ophthalmic compositions comprising biopolymers, as well as methods of use.

A method for stabilizing a composition for ophthalmic use containing sepetaprost is disclosed. More specifically, a method that facilitates retention of sepetaprost stability at high temperatures, and further, a method that facilitates the retention of preservative effectiveness of the composition for ophthalmic use are disclosed. The composition for ophthalmic use contains sepetaprost at a concentration of 0.0001 to 0.003% (w / v) and has a pH within a range from 5 to 8.

The purpose of the present invention is to discover a method for stabilizing a composition for ophthalmic use containing sepetaprost, more specifically, a method that facilitates retention of sepetaprost stability at high temperatures, and further, a method that facilitates the retention of preservative effectiveness of this composition for ophthalmic use. The present invention is a composition for ophthalmic use, which contains sepetaprost at a concentration of 0.0001 to 0.003% (w / v) and has a pH within a range from 5 to 8.

The utility model discloses a medical atomization eyeshade for the ophthalmology department, and relates to the technical field of atomization eyeshades. The eyeshade comprises two eyeshade bodies, connecting rings are fixedly connected to the opposite sides of the eyeshade bodies, annular grooves are formed in the side faces of the connecting rings, two protrusions distributed in a central symmetry mode are fixedly connected to the sides, close to each other, of the connecting rings, and a three-way pipe is arranged between the two eyeshade bodies. Appropriate rotation starting torque is applied to the three-way pipe, due to the soft property of plastic materials, the protrusions are disengaged from the interiors of the grooves, the annular sliding rails are driven to slide along the inner sides of the annular grooves, and when the three-way pipe vertically rotates by 90 degrees, the protrusions correspond to the other grooves in position and are clamped into the grooves again, so that the three-way pipe is prevented from rotating. And the three-way pipe is reversely rotated, in the same way, the three-way pipe is reset, and the flexibility of the equipment is further improved.

The present invention relates to an eye drop composition comprising imatinib. The present invention relates to an eye drop composition and a method for preparing same, in which the eye drop composition is prepared at a pH level suitable as an eye drop while an appropriate amount of an imatinib derivative is dissolved even within a relatively high pH range, compared to conventional compositions prepared under pH conditions (< pH 5.5) unsuitable for eye drop, in order to dissolve imatinib, and has improved phase stability, long-term stability, bioavailability, and eye irritation.

The present invention relates to novel pharmaceutical compositions containing antibiotics, such as plazomycin or a pharmaceutically acceptable salt thereof, suitable for ophthalmic use for use in the treatment of eye infections, and methods for their preparation.

A gel formulation for topical ophthalmic use, the gel formulation comprising a compound of formula (I).

A pharmaceutical composition is disclosed comprising an insulin, a set of excipients, and a penetration enhancer, wherein the penetration enhancer is a prostaglandin analogue configured to enhance the permeability of insulin upon topical ocular administration. The composition enables increased transport of insulin across ocular tissues, improving absorption and bioavailability following topical delivery to the eye. The formulation includes pharmaceutically acceptable excipients such as surfactants, buffering agents, viscosity enhancers, tonicity agents, preservatives, and solvents suitable for ophthalmic use. The invention provides a non-invasive route of administering insulin through the eye, allowing systemic or local therapeutic effects without injection.

Implantable or wearable lens for ophthalmic use, having a front surface and a rear surface, wherein at least one surface of said front surface and rear surface has a refractive profile of the multi-zone aspheric type with circular or rotational symmetry, with respect to the optical axis, and having a geometric elevation z(r) defined by a Forbes polynomial series expansion. This refractive profile enhances the wavefront W(r) emerging from the lens, progressively and continuously extending the depth of field in a range of powers preferably comprised between -1,0D and 4.0D; and improves the quality of vision in Far Field for pupil diameters greater than a value ϕ. Furthermore, the rear surface of the lens can include a toric-type profile adapted to correct residual corneal astigmatism.